nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—BCHE—multiple sclerosis	0.646	1	CbGaD
Triflupromazine—BCHE—Triamcinolone—multiple sclerosis	0.125	0.409	CbGbCtD
Triflupromazine—ABCB1—Methylprednisolone—multiple sclerosis	0.0419	0.137	CbGbCtD
Triflupromazine—ABCB1—Mitoxantrone—multiple sclerosis	0.0306	0.1	CbGbCtD
Triflupromazine—ABCB1—Betamethasone—multiple sclerosis	0.0273	0.0891	CbGbCtD
Triflupromazine—ABCB1—Prednisolone—multiple sclerosis	0.0269	0.0879	CbGbCtD
Triflupromazine—ABCB1—Prednisone—multiple sclerosis	0.0254	0.083	CbGbCtD
Triflupromazine—ABCB1—Dexamethasone—multiple sclerosis	0.0159	0.0518	CbGbCtD
Triflupromazine—ABCB1—Methotrexate—multiple sclerosis	0.0127	0.0417	CbGbCtD
Triflupromazine—DRD1—nerve—multiple sclerosis	0.00263	0.141	CbGeAlD
Triflupromazine—DRD2—nerve—multiple sclerosis	0.00156	0.0832	CbGeAlD
Triflupromazine—DRD1—brainstem—multiple sclerosis	0.00113	0.0605	CbGeAlD
Triflupromazine—DRD1—midbrain—multiple sclerosis	0.000721	0.0385	CbGeAlD
Triflupromazine—DRD2—brainstem—multiple sclerosis	0.000668	0.0357	CbGeAlD
Triflupromazine—DRD2—retina—multiple sclerosis	0.000644	0.0345	CbGeAlD
Triflupromazine—BCHE—brainstem—multiple sclerosis	0.000606	0.0324	CbGeAlD
Triflupromazine—DRD1—nervous system—multiple sclerosis	0.000592	0.0317	CbGeAlD
Triflupromazine—DRD1—central nervous system—multiple sclerosis	0.00057	0.0305	CbGeAlD
Triflupromazine—CHRM2—nervous system—multiple sclerosis	0.000477	0.0255	CbGeAlD
Triflupromazine—CHRM2—central nervous system—multiple sclerosis	0.00046	0.0246	CbGeAlD
Triflupromazine—DRD1—brain—multiple sclerosis	0.000453	0.0242	CbGeAlD
Triflupromazine—CHRM1—nervous system—multiple sclerosis	0.000435	0.0232	CbGeAlD
Triflupromazine—HTR2B—nervous system—multiple sclerosis	0.000432	0.0231	CbGeAlD
Triflupromazine—DRD2—midbrain—multiple sclerosis	0.000426	0.0228	CbGeAlD
Triflupromazine—BCHE—medulla oblongata—multiple sclerosis	0.000422	0.0226	CbGeAlD
Triflupromazine—CHRM1—central nervous system—multiple sclerosis	0.000418	0.0224	CbGeAlD
Triflupromazine—HTR2B—central nervous system—multiple sclerosis	0.000416	0.0223	CbGeAlD
Triflupromazine—BCHE—midbrain—multiple sclerosis	0.000386	0.0207	CbGeAlD
Triflupromazine—BCHE—spinal cord—multiple sclerosis	0.000377	0.0202	CbGeAlD
Triflupromazine—CHRM2—brain—multiple sclerosis	0.000365	0.0195	CbGeAlD
Triflupromazine—DRD2—nervous system—multiple sclerosis	0.00035	0.0187	CbGeAlD
Triflupromazine—DRD2—central nervous system—multiple sclerosis	0.000337	0.018	CbGeAlD
Triflupromazine—CHRM1—brain—multiple sclerosis	0.000332	0.0178	CbGeAlD
Triflupromazine—HTR2B—brain—multiple sclerosis	0.00033	0.0177	CbGeAlD
Triflupromazine—DRD2—cerebellum—multiple sclerosis	0.000329	0.0176	CbGeAlD
Triflupromazine—BCHE—nervous system—multiple sclerosis	0.000317	0.017	CbGeAlD
Triflupromazine—BCHE—central nervous system—multiple sclerosis	0.000306	0.0163	CbGeAlD
Triflupromazine—BCHE—cerebellum—multiple sclerosis	0.000299	0.016	CbGeAlD
Triflupromazine—ABCB1—retina—multiple sclerosis	0.000279	0.0149	CbGeAlD
Triflupromazine—Ethopropazine—BCHE—multiple sclerosis	0.000271	0.369	CrCbGaD
Triflupromazine—DRD2—brain—multiple sclerosis	0.000268	0.0143	CbGeAlD
Triflupromazine—BCHE—brain—multiple sclerosis	0.000243	0.013	CbGeAlD
Triflupromazine—ABCB1—medulla oblongata—multiple sclerosis	0.000201	0.0108	CbGeAlD
Triflupromazine—ABCB1—midbrain—multiple sclerosis	0.000184	0.00984	CbGeAlD
Triflupromazine—ABCB1—spinal cord—multiple sclerosis	0.00018	0.0096	CbGeAlD
Triflupromazine—ABCB1—nervous system—multiple sclerosis	0.000151	0.00809	CbGeAlD
Triflupromazine—ABCB1—central nervous system—multiple sclerosis	0.000146	0.00779	CbGeAlD
Triflupromazine—ABCB1—cerebellum—multiple sclerosis	0.000142	0.00761	CbGeAlD
Triflupromazine—ABCB1—brain—multiple sclerosis	0.000116	0.00619	CbGeAlD
Triflupromazine—Chlorpromazine—BCHE—multiple sclerosis	0.000107	0.146	CrCbGaD
Triflupromazine—Acepromazine—ALB—multiple sclerosis	8.44e-05	0.115	CrCbGaD
Triflupromazine—Thioproperazine—ALB—multiple sclerosis	8.25e-05	0.112	CrCbGaD
Triflupromazine—Pipotiazine—ALB—multiple sclerosis	8.11e-05	0.111	CrCbGaD
Triflupromazine—Clomipramine—ALB—multiple sclerosis	6.41e-05	0.0874	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—multiple sclerosis	4.4e-05	0.0599	CrCbGaD
Triflupromazine—BCHE—Neuronal System—MAPK1—multiple sclerosis	2.14e-05	0.000741	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.14e-05	0.000741	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	2.12e-05	0.000735	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CCL5—multiple sclerosis	2.12e-05	0.000734	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GPR65—multiple sclerosis	2.11e-05	0.000733	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	2.11e-05	0.000731	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CCR5—multiple sclerosis	2.1e-05	0.000729	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	2.1e-05	0.000727	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	2.09e-05	0.000726	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.07e-05	0.000718	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	2.07e-05	0.000718	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—POMC—multiple sclerosis	2.07e-05	0.000717	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	2.07e-05	0.000717	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.06e-05	0.000716	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.06e-05	0.000716	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	2.06e-05	0.000715	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	2.04e-05	0.000708	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	2.04e-05	0.000706	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.03e-05	0.000704	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	2.03e-05	0.000702	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	2.02e-05	0.000702	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	2e-05	0.000693	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCL5—multiple sclerosis	2e-05	0.000693	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.99e-05	0.00069	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CCR5—multiple sclerosis	1.98e-05	0.000687	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	1.98e-05	0.000687	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	1.96e-05	0.000678	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.95e-05	0.000677	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.95e-05	0.000675	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	1.95e-05	0.000675	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL3—multiple sclerosis	1.93e-05	0.000671	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR1—multiple sclerosis	1.93e-05	0.00067	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	1.93e-05	0.00067	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.93e-05	0.000669	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	1.91e-05	0.000662	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	1.9e-05	0.00066	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	1.89e-05	0.000656	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	1.89e-05	0.000656	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.89e-05	0.000655	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.89e-05	0.000655	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	1.88e-05	0.000652	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	1.88e-05	0.000652	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	1.87e-05	0.000647	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	1.87e-05	0.000647	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.86e-05	0.000646	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	1.86e-05	0.000646	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—POMC—multiple sclerosis	1.85e-05	0.00064	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PGR—multiple sclerosis	1.83e-05	0.000636	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL3—multiple sclerosis	1.82e-05	0.000632	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	1.81e-05	0.000626	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCR5—multiple sclerosis	1.8e-05	0.000624	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	1.8e-05	0.000623	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CD28—multiple sclerosis	1.78e-05	0.000618	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL2RA—multiple sclerosis	1.77e-05	0.000615	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTGER4—multiple sclerosis	1.76e-05	0.000609	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	1.75e-05	0.000607	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	1.75e-05	0.000606	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PGR—multiple sclerosis	1.73e-05	0.0006	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	1.71e-05	0.000594	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCR3—multiple sclerosis	1.7e-05	0.000588	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	1.69e-05	0.000587	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	1.68e-05	0.000583	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CD28—multiple sclerosis	1.68e-05	0.000582	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	1.66e-05	0.000576	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR2—multiple sclerosis	1.65e-05	0.000572	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	1.65e-05	0.000571	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	1.64e-05	0.000569	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	1.63e-05	0.000563	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	1.61e-05	0.00056	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	1.6e-05	0.000556	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.56e-05	0.000542	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.56e-05	0.000541	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—POMC—multiple sclerosis	1.55e-05	0.000537	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CNR1—multiple sclerosis	1.52e-05	0.000528	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	1.51e-05	0.000523	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	1.5e-05	0.000519	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	1.49e-05	0.000517	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	1.48e-05	0.000512	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.47e-05	0.000511	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	1.46e-05	0.000508	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	1.46e-05	0.000506	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	1.46e-05	0.000505	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	1.45e-05	0.000504	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	1.45e-05	0.000501	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.44e-05	0.0005	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.44e-05	0.0005	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.44e-05	0.000499	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.42e-05	0.000494	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.41e-05	0.00049	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—POMC—multiple sclerosis	1.41e-05	0.000488	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	1.38e-05	0.000477	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCL2—multiple sclerosis	1.38e-05	0.000477	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL10—multiple sclerosis	1.37e-05	0.000475	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	1.36e-05	0.000471	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	1.35e-05	0.000467	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.34e-05	0.000466	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	1.34e-05	0.000464	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.33e-05	0.000461	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	1.33e-05	0.000461	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	1.33e-05	0.00046	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	1.33e-05	0.000459	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.31e-05	0.000455	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.31e-05	0.000454	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PGR—multiple sclerosis	1.31e-05	0.000453	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	1.3e-05	0.00045	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.29e-05	0.000449	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.28e-05	0.000444	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	1.28e-05	0.000444	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	1.28e-05	0.000443	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CD86—multiple sclerosis	1.27e-05	0.000441	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CD28—multiple sclerosis	1.27e-05	0.00044	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.26e-05	0.000437	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	1.25e-05	0.000434	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	1.25e-05	0.000434	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—TYK2—multiple sclerosis	1.25e-05	0.000433	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	1.25e-05	0.000432	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	1.24e-05	0.00043	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.24e-05	0.000429	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.23e-05	0.000425	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	1.22e-05	0.000423	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	1.21e-05	0.000421	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.2e-05	0.000417	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CD86—multiple sclerosis	1.2e-05	0.000416	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL5—multiple sclerosis	1.18e-05	0.000409	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	1.17e-05	0.000405	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	1.16e-05	0.000402	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	1.15e-05	0.000399	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—IL2—multiple sclerosis	1.15e-05	0.000397	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.14e-05	0.000397	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	1.13e-05	0.000392	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	1.13e-05	0.000391	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	1.13e-05	0.00039	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	1.11e-05	0.000385	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	1.11e-05	0.000385	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOE—multiple sclerosis	1.11e-05	0.000384	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	1.1e-05	0.000382	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SPP1—multiple sclerosis	1.09e-05	0.000379	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR5—multiple sclerosis	1.06e-05	0.000369	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	1.06e-05	0.000368	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	0.000363	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL2—multiple sclerosis	1.04e-05	0.00036	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	1.04e-05	0.00036	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	1.04e-05	0.00036	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	1.04e-05	0.000359	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	1.03e-05	0.000356	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.03e-05	0.000356	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.02e-05	0.000353	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.01e-05	0.000351	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	1e-05	0.000348	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	1e-05	0.000347	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—multiple sclerosis	9.67e-06	0.000335	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—POMC—multiple sclerosis	9.52e-06	0.00033	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	9.44e-06	0.000327	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	9.27e-06	0.000321	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	9.23e-06	0.00032	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	9.12e-06	0.000316	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CD86—multiple sclerosis	9.05e-06	0.000314	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.04e-06	0.000313	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—BCHE—multiple sclerosis	8.99e-06	0.000312	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	8.91e-06	0.000309	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	8.86e-06	0.000307	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	8.81e-06	0.000305	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CD80—multiple sclerosis	8.75e-06	0.000303	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	8.74e-06	0.000303	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	8.72e-06	0.000302	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—multiple sclerosis	8.68e-06	0.000301	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	8.65e-06	0.0003	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	8.62e-06	0.000299	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	8.61e-06	0.000298	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	8.46e-06	0.000293	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	8.44e-06	0.000292	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	8.35e-06	0.00029	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—POMC—multiple sclerosis	8.31e-06	0.000288	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	8.25e-06	0.000286	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL2—multiple sclerosis	8.13e-06	0.000282	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	8.08e-06	0.00028	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	8.03e-06	0.000278	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	7.97e-06	0.000276	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	7.95e-06	0.000276	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	7.91e-06	0.000274	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	7.86e-06	0.000272	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	7.85e-06	0.000272	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	7.83e-06	0.000271	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	7.76e-06	0.000269	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	7.74e-06	0.000268	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	7.68e-06	0.000266	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	7.64e-06	0.000265	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	7.59e-06	0.000263	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	7.38e-06	0.000256	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	7.3e-06	0.000253	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	7.15e-06	0.000248	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	7.06e-06	0.000245	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	6.6e-06	0.000229	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	6.51e-06	0.000226	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	6.48e-06	0.000225	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	6.46e-06	0.000224	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	6.38e-06	0.000221	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	6.27e-06	0.000217	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	6.17e-06	0.000214	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2—multiple sclerosis	6.14e-06	0.000213	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	6.14e-06	0.000213	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	6.14e-06	0.000213	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	6.11e-06	0.000212	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	6.06e-06	0.00021	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	6.01e-06	0.000208	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	6.01e-06	0.000208	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	5.93e-06	0.000206	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.88e-06	0.000204	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	5.81e-06	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.8e-06	0.000201	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	5.57e-06	0.000193	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	5.48e-06	0.00019	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	5.46e-06	0.000189	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—multiple sclerosis	5.41e-06	0.000187	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	5.39e-06	0.000187	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	5.17e-06	0.000179	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	5.09e-06	0.000177	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	5.08e-06	0.000176	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	4.98e-06	0.000173	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—multiple sclerosis	4.8e-06	0.000167	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	4.79e-06	0.000166	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	4.7e-06	0.000163	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—POMC—multiple sclerosis	4.64e-06	0.000161	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	4.64e-06	0.000161	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	4.61e-06	0.00016	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	4.54e-06	0.000157	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	4.52e-06	0.000157	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.48e-06	0.000155	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	4.46e-06	0.000155	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	4.39e-06	0.000152	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.3e-06	0.000149	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.24e-06	0.000147	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—multiple sclerosis	4.23e-06	0.000147	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	3.9e-06	0.000135	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	3.83e-06	0.000133	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	3.82e-06	0.000132	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.77e-06	0.000131	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	3.63e-06	0.000126	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	3.62e-06	0.000125	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—multiple sclerosis	3.61e-06	0.000125	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	3.55e-06	0.000123	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	3.55e-06	0.000123	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.54e-06	0.000123	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.5e-06	0.000121	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.5e-06	0.000121	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.47e-06	0.00012	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.43e-06	0.000119	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	2.73e-06	9.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.67e-06	9.25e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.63e-06	9.13e-05	CbGpPWpGaD
